New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment-Reference-Cited by-同舟云学术

New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment

Published:2023-08-18 Issue:11 Volume:32 Page:2334-2348
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Mehihi Abbas A. Ridha,Kubba Ammar A. Razzak,Shihab Wurood A.,Tahtamouni Lubna H.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s00044-023-03137-4.pdf

Reference43 articles.

1. Maiti P, Sharma P, Nand M, Bhatt ID, Ramakrishnan MA, Mathpal S, et al. Integrated machine learning and chemoinformatics-based screening of mycotic compounds against kinesin spindle ProteinEg5 for lung cancer therapy. Molecules. 2022;27:1639. https://doi.org/10.3390/molecules27051639.

2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–24. https://doi.org/10.3322/caac.21492.

3. Nara S, Garlapati A. Design, synthesis and molecular docking study of hybrids of quinazolin-4(3H)-one as anticancer agents. Ars Pharm. 2018;59:121–31. https://doi.org/10.1016/j.bmcl.2016.08.

4. Ahmadvand D, Rahbarizadeh F, Iri-Sofla FJ, Namazi G, Khaleghi S, Geramizadeh B, et al. Inhibition of angiogenesis by recombinant VEGF receptor fragments. Lab Med. 2010;41:417–22. https://doi.org/10.1309/LMMH2WYRLP7B3HJN.

5. Alsaif NA, Taghour MS, Alanazi MM, Obaidullah AJ, Al-Mehizia AA, Alanaz MM, et al. Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo) [4, 3-a: 3’, 4’-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. J Enzyme Inhib Med Chem. 2021;36:1093–14. https://doi.org/10.1080/14756366.2021.1915303.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors;Current Medicinal Chemistry;2024-11

2. Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors;Bioorganic Chemistry;2024-09

3. In vitro and in silico evaluation of 4'-hydroxy-[1,1'-biphenyl]-4-carbohydrazide Schiff base and oxadiazole derivatives targeting EGFR allosteric site;Chemical Papers;2024-08-19

4. The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs;Future Medicinal Chemistry;2024-04-04